The Scientist

» clinical trials, evolution and ecology

Most Recent

image: FDA OKs Clinical Trials of Ecstasy for PTSD

FDA OKs Clinical Trials of Ecstasy for PTSD

By | December 1, 2016

The illicit drug has shown promise in helping people with debilitating post-traumatic stress disorder.

0 Comments

Scientists are enlisting the help of pigeons, parrots, crows, jays, and other species to disprove the notion that human cognitive abilities are beyond those of other animals.

1 Comment

Spruce and pine and have relied on similar genetic toolkits for climate adaptation despite millions of years of evolution.

0 Comments

image: Elephant Footprints Create Habitat for Tiny Aquatic Creatures

Elephant Footprints Create Habitat for Tiny Aquatic Creatures

By | December 1, 2016

Researchers discover diverse communities of invertebrates inhabiting the water-filled tracks of elephants in Uganda.

0 Comments

A family’s collection of antique microscope slides became a trove of genetic information about the eradicated European malaria pathogen.

0 Comments

image: Opinion: Not All Genetic Databases Are Equal

Opinion: Not All Genetic Databases Are Equal

By | December 1, 2016

Sorting out which data sets are clinical-grade is key to helping patients.

0 Comments

image: The Topography of Teeth

The Topography of Teeth

By | November 29, 2016

Intricate, digital maps of animals’ teeth, created using the same geographical tools used by mapmakers, may help researchers determine the diets of extinct species.

0 Comments

image: Evolution May Have Deleted Neanderthal DNA

Evolution May Have Deleted Neanderthal DNA

By | November 9, 2016

Natural selection may be behind the dearth of Neanderthal DNA in modern humans.

1 Comment

image: Ebola Evolved to Be More Infectious

Ebola Evolved to Be More Infectious

By | November 7, 2016

A mutation that appeared early in the 2014 outbreak made the virus more infectious in humans, scientists show.

0 Comments

image: New Support for Experimental Alzheimer’s Drug

New Support for Experimental Alzheimer’s Drug

By | November 2, 2016

Merck’s verubecestat, which is currently being tested in two Phase 3 studies, is safe, according to newly published Phase 1 data.

2 Comments

Popular Now

  1. Gut Microbes Linked to Neurodegenerative Disease
  2. Opinion: WHO’s Silence on Cannabis
  3. Top 10 Innovations 2016
    Features Top 10 Innovations 2016

    This year’s list of winners celebrates both large leaps and small (but important) steps in life science technology.

  4. Infant Microbiome: Vaginal Delivery Versus C-Section
Rockland